Comparison of Molecular Changes in Lung Cancers in HIV-Positive and HIV-Indeterminate Subjects

Abstract
HUMAN immunodeficiency virus (HIV) infection has an established predisposition to certain malignancies (acquired immunodeficiency syndrome [AIDS]-defining neoplasms), including Kaposi sarcoma, primary central nervous system lymphoma, non-Hodgkin lymphoma, and cervical carcinoma.1 As the AIDS epidemic advances, the number of HIV-infected subjects developing AIDS-related neoplasms has increased, and the spectrum of malignancies is expanding. Several non–AIDS-defining cancers, including lung cancer,2 are being reported at increasing incidences in HIV-infected persons.